Ásar hf. - Reglubundin tilkynning um kaup á eigin bréfum í samræmi við endurkaupaáætlun

Ásar hf. repurchased 3.9 million of its own shares in the 40th week of 2026 for ISK 43.55 million, at transaction prices of ISK 11.15–11.20 per share. The company now holds 118,668,958 treasury shares, equal to 4.94% of issued shares; cumulative purchases under the program total 13.05 million shares for ISK 145.1525 million. The buyback program has a maximum amount of ISK 399.7125 million and remains subject to its stated time and purchase limits.

Analysis

The signal is execution, not proof of undervaluation: the week’s purchases are about 10.9% of the program’s stated cash ceiling, while cumulative purchases under the program are about 36%. At the reported pace, the remaining authorization could provide a near-term bid, but the program runs only until the 2027 AGM at the latest; do not extrapolate this week’s activity into a durable floor. The 4.94% treasury-share figure includes a substantial balance held before this program, so it should not be read as 4.94% of new demand or capital returned under the current authorization. The incremental 0.54% acquired under the program is too small, absent a low valuation or a shrinking share count through cancellation, to support a meaningful earnings-per-share re-rating on its own. Over 1–3 months, price support depends on continued execution and the remaining authorization; over 6–18 months, the key questions are whether shares are cancelled or reissued and whether buybacks crowd out dividends, investment, or balance-sheet flexibility. The notice provides no valuation, liquidity, or funding context. A reversal in purchases, weak operating results, or treasury shares being reissued would undermine the supportive interpretation.

Key Decisions for Investors

• No standalone directional trade on this notice: treat the buyback as a modest, time-limited demand signal, not an independently verified valuation catalyst.
• Track weekly filings against the 399.7m kr. ceiling and the 2027 AGM deadline. Reassess only if execution continues consistently and the share price remains below a defensible estimate of intrinsic value; do not infer that value from repurchase prices alone.
• Before assigning EPS or capital-return upside, verify the issued-share denominator, the treatment of treasury shares (cancellation versus possible reissue), program cash funding, and the company’s operating and liquidity outlook.
• Falsifiers: buyback activity pauses or ends materially below the authorization; guidance or earnings weaken; or treasury shares are reissued. These would reduce the case that repurchases provide durable per-share support.